Oxoferryl complex (Fe(IV)=O)

The oxoferryl complex is a high-valent iron species, typically existing in the iron(IV)-oxo (Fe(IV)=O) state, that serves as a pivotal reactive intermediate in the catalytic cycles of numerous heme and non-heme iron enzymes. In proteins such as Cytochrome P450, Myeloperoxidase, and Catalase, these complexes—often identified as Compound I and Compound II—are the primary oxidants responsible for essential metabolic reactions, including substrate hydroxylation and the decomposition of hydrogen peroxide. However, the aberrant formation of oxoferryl species in oxygen-transport proteins like hemoglobin and myoglobin under oxidative stress can lead to significant cellular damage, including lipid peroxidation, protein cross-linking, and the release of toxic free iron. These oxidative processes are heavily implicated in the pathogenesis of inflammatory and cardiovascular conditions, such as atherosclerosis and myocardial ischemia-reperfusion injury. Consequently, the oxoferryl complex is a target for therapeutic antioxidants like resveratrol and melatonin, which act by reducing the high-valent iron back to its inactive ferric state, thereby mitigating oxidative tissue injury. Additionally, modern pharmacological strategies involve developing specific peroxidase inhibitors that prevent the catalytic generation of these potent oxidants to treat chronic inflammatory diseases.

Other names

Ferryl ironCompound ICompound IIIron(IV)-oxo speciesFerryl-oxo intermediateHigh-valent iron species

Quenching of the high-valent iron(IV) oxidative state through one-electron or two-electron reduction back to the stable ferric (Fe(III)) or ferrous (Fe(II)) states, or the inhibition of enzymatic cycles (e.g., Myeloperoxidase) that generate these reactive intermediates.